StonvexLoading…
StonvexStonvexStonvexCore line items from RIVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.39B | $4.97B | $4.43B | $1.66B |
Operating Income | $-3.58B | $-4.69B | $-5.74B | $-6.86B |
Net Income | $-3.65B | $-4.75B | $-5.43B | $-6.75B |
EPS (Diluted) | $-3.07 | $-4.69 | $-5.74 | $-7.40 |
Total Assets | $14.86B | $15.41B | $16.78B | $17.88B |
Total Liabilities | $10.27B | $8.85B | $7.64B | $4.08B |
Cash & Equivalents | $3.58B | $5.29B | $7.86B | $11.57B |
Free Cash Flow OCF − CapEx | $-2.49B | $-2.86B | $-5.89B | $-6.42B |
Shares Outstanding | 1.24B | 1.13B | 968.00M | 926.00M |